MX2009013044A - Microorganismos de la leche de mamiferos, composiciones que los contienen y su uso para el tratamiento de la mastitis. - Google Patents

Microorganismos de la leche de mamiferos, composiciones que los contienen y su uso para el tratamiento de la mastitis.

Info

Publication number
MX2009013044A
MX2009013044A MX2009013044A MX2009013044A MX2009013044A MX 2009013044 A MX2009013044 A MX 2009013044A MX 2009013044 A MX2009013044 A MX 2009013044A MX 2009013044 A MX2009013044 A MX 2009013044A MX 2009013044 A MX2009013044 A MX 2009013044A
Authority
MX
Mexico
Prior art keywords
mastitis
treatment
compositions containing
mammalian milk
milk
Prior art date
Application number
MX2009013044A
Other languages
English (en)
Spanish (es)
Inventor
Rocio Martin Jimenez
Monica Olivares Martin
Esther Antonia Jimenez Quintana
Maria Luisa Marin Martinez
Saleta Sierra Avila
Antonio Maldonado Barragan
Virginia Martin Merino
Francesc Blanch Martell
Celina Torre Lloveras
Federico Lara Villoslada
Rebeca Arroyo Rodriguez
Julio Boza Puerta
Jesus Jimenez Lopez
Leonides Fernandez Alvarez
Odon Julian Sobrino Abuja
Jordi Xaus Pei
Juan Miguel Rodriguez Gomez
Susana Delgado Palacio
Original Assignee
Puleva Biotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puleva Biotech Sa filed Critical Puleva Biotech Sa
Publication of MX2009013044A publication Critical patent/MX2009013044A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
MX2009013044A 2007-05-31 2008-06-02 Microorganismos de la leche de mamiferos, composiciones que los contienen y su uso para el tratamiento de la mastitis. MX2009013044A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380158A EP1997499A1 (en) 2007-05-31 2007-05-31 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
PCT/EP2008/056768 WO2008145756A1 (en) 2007-05-31 2008-06-02 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis

Publications (1)

Publication Number Publication Date
MX2009013044A true MX2009013044A (es) 2010-04-12

Family

ID=38657070

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013044A MX2009013044A (es) 2007-05-31 2008-06-02 Microorganismos de la leche de mamiferos, composiciones que los contienen y su uso para el tratamiento de la mastitis.

Country Status (16)

Country Link
US (1) US8557560B2 (enExample)
EP (2) EP1997499A1 (enExample)
JP (1) JP5710250B2 (enExample)
AU (1) AU2008257455B2 (enExample)
CA (1) CA2689360C (enExample)
CO (1) CO6270334A2 (enExample)
DK (1) DK2162143T3 (enExample)
ES (1) ES2555159T3 (enExample)
HU (1) HUE025851T2 (enExample)
IL (1) IL202386A0 (enExample)
MX (1) MX2009013044A (enExample)
NZ (1) NZ581576A (enExample)
PL (1) PL2162143T3 (enExample)
PT (1) PT2162143E (enExample)
RU (1) RU2446814C2 (enExample)
WO (1) WO2008145756A1 (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
RU2476591C1 (ru) * 2011-08-19 2013-02-27 Федеральное государственное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм enterococcus hirae, используемый для приготовления кисломолочных продуктов
RU2477313C1 (ru) * 2011-08-25 2013-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ Enterococcus hirae, ИСПОЛЬЗУЕМЫЙ ПРИ ПРОИЗВОДСТВЕ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ
RU2476592C1 (ru) * 2011-09-02 2013-02-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм enterococcus hirae, используемый для производства кисломолочных продуктов
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2830599B1 (en) 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US20160066582A1 (en) 2013-04-23 2016-03-10 Terragen Holdings Limited Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
DE102013105666A1 (de) * 2013-06-03 2014-12-04 Hochschule Hannover Probiotische Stämme, Zusammensetzungen enthaltend probiotische Stämme sowie pharmazeutische Mittel
EP2818056A1 (en) 2013-06-25 2014-12-31 Biosearch S.A. Probiotic bacteria comprising metals, metal nanoparticles and uses thereof
US20150057574A1 (en) 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
ES2615808T3 (es) 2013-10-16 2017-06-08 Casen Recordati, S.L. Microorganismos y composiciones que los comprenden para su uso en el tratamiento o prevención de mastitis
WO2015093937A1 (en) * 2013-12-19 2015-06-25 N.V. Nutricia Lactobacillus salivarius for the treatment of mastitis
CA2965214C (en) 2014-10-21 2022-01-11 Aquilon Cyl Sociedad Limitada Probiotic and prebiotic compositions
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
HK1248756A1 (zh) * 2015-01-16 2018-10-19 Biogaia Ab 乳酸菌及其用於治疗乳腺炎的用途
EP3250217A1 (en) * 2015-01-30 2017-12-06 Technische Universität München Composition for use in preventing and/or treating diarrhea in animals
EP3277255A1 (en) 2015-03-31 2018-02-07 GOJO Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SK542015A3 (sk) * 2015-07-30 2017-02-02 Univerzita Pavla Jozefa Šafárika V Košiciach Kmene mikroorganizmov Lactobacillus Plantarum LS/07 CCM 7766 a spôsob ich využitia
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108495643A (zh) * 2015-12-24 2018-09-04 天天乳品有限公司 新型发酵乳杆菌菌株的组合物和使用方法
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN110475853A (zh) * 2017-01-13 2019-11-19 益福生医股份有限公司 新颖乳酸菌及其应用
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
US11730171B2 (en) 2018-03-23 2023-08-22 Morinaga Milk Industry Co., Ltd. Composition for enhancing breast milk component
US20220184153A1 (en) * 2019-03-25 2022-06-16 The State of Israel, Ministry of Agriculture&Rural Development, Agricltural Research Oganization(ARO Method of treating bovine mastitis
EP3996510A4 (en) * 2019-07-08 2023-08-09 BioPlx, Inc. LIVING BIOTHERAPEUTIC COMPOSITIONS AND PROCESSES
EP4065146A1 (en) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CL2019003739A1 (es) * 2019-12-18 2020-06-19 Univ Concepcion Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos.
JP2022150100A (ja) * 2021-03-26 2022-10-07 清竺 遠藤 乳汁の体細胞数減少用又は乳量増加用組成物
CN117338823A (zh) * 2023-12-06 2024-01-05 山东百德生物科技有限公司 一种动物酵素发酵液及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591499A (en) 1984-01-20 1986-05-27 J. B. Lima, Inc. Method for treatment and prevention of mastitis
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
SI1565547T2 (sl) * 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
IE20030773A1 (en) * 2003-10-17 2005-04-20 Teagasc Agric Food Dev Authori Use of probiotic bacteria in the treatment of infection
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy

Also Published As

Publication number Publication date
AU2008257455A1 (en) 2008-12-04
ES2555159T3 (es) 2015-12-29
HUE025851T2 (en) 2016-04-28
IL202386A0 (en) 2010-06-30
RU2446814C2 (ru) 2012-04-10
PT2162143E (pt) 2016-01-07
WO2008145756A1 (en) 2008-12-04
JP2010528093A (ja) 2010-08-19
EP2162143A1 (en) 2010-03-17
NZ581576A (en) 2012-01-12
CA2689360A1 (en) 2008-12-04
US8557560B2 (en) 2013-10-15
AU2008257455B2 (en) 2014-05-01
EP1997499A1 (en) 2008-12-03
EP2162143B1 (en) 2015-09-09
RU2009149393A (ru) 2011-07-10
US20100266550A1 (en) 2010-10-21
PL2162143T3 (pl) 2016-03-31
DK2162143T3 (en) 2015-12-14
BRPI0811973A2 (pt) 2014-10-21
CO6270334A2 (es) 2011-04-20
JP5710250B2 (ja) 2015-04-30
CA2689360C (en) 2017-03-14

Similar Documents

Publication Publication Date Title
IL202386A0 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
IN2014KN02933A (enExample)
PH12018501264A1 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
PH12015500297A1 (en) Adoptosis-inducing agents for the treatment of cancer and immune and automoimmune disease
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
MY179077A (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
MY161340A (en) Apoptosis-Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
TN2012000555A1 (en) Antibodies to human gdf8
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
MX351670B (es) Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos.
MY176900A (en) Antimicrobial compounds and methods of making and using the same
SG185638A1 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
MX338201B (es) Bacterias acidolacticas de postacidificion baja.
PH12015502375B1 (en) Antimicrobial compounds and methods of making and using the same
MX356959B (es) Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
WO2019178487A3 (en) Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
PH12021552133A1 (en) Aromatic derivatives, preparation methods, and medical uses thereof
MY165011A (en) Antimicrobial compounds and methods of making and using the same
TW200716162A (en) Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
WO2011019636A3 (en) Methods and compositions for the treatment of cancers and pathogenic infections
WO2011160048A3 (en) Methods of identifying therapeutic agents for treating persister and bacterial infection
PH12021550070A1 (en) Composition for inactivation of gram-positive bacteria and bacterial spores and mehtods of making and using same
NZ713741A (en) Antimicrobial compounds and methods of making and using the same
MY134740A (en) Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter
FR2896379B1 (fr) Composition pour le traitement curatif ou preventif des plantes contre les pathogenes, son procede de preparation et son utilisation.

Legal Events

Date Code Title Description
FG Grant or registration